Compare SLQT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | CSBR |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.3M | 81.0M |
| IPO Year | 2020 | 2015 |
| Metric | SLQT | CSBR |
|---|---|---|
| Price | $0.47 | $5.08 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.88 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 8.2K |
| Earning Date | 05-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,618,499,000.00 | $2,900,000.00 |
| Revenue This Year | $10.97 | $4.84 |
| Revenue Next Year | $6.14 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.02 | N/A |
| 52 Week Low | $0.48 | $4.83 |
| 52 Week High | $2.22 | $8.31 |
| Indicator | SLQT | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 35.73 | 35.60 |
| Support Level | $0.48 | N/A |
| Resistance Level | $0.79 | $6.31 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 33.47 | 8.70 |
SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.